Publicacións en colaboración con investigadores/as de AstraZeneca (United Kingdom) (6)

2021

  1. The risk of infections in adult patients with systemic lupus erythematosus: Systematic review and meta-Analysis

    Rheumatology (United Kingdom), Vol. 60, Núm. 1, pp. 60-72

2016

  1. EGFR testing and clinical management of advanced NSCLC: A galician lung cancer group study (GGCP 048-10)

    Cancer Management and Research, Vol. 8, pp. 11-20

2012

  1. Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia

    Comprehensive Psychiatry, Vol. 53, Núm. 2, pp. 145-151

2008

  1. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia

    International Clinical Psychopharmacology, Vol. 23, Núm. 3, pp. 138-149

2007

  1. The Meropenem Yearly Susceptibility Test Information Collection antimicrobial susceptibility program in Spain: a 5-year analysis

    Diagnostic Microbiology and Infectious Disease, Vol. 57, Núm. 2, pp. 195-200

2005

  1. A 6-month prospective observational study on the effects of quetiapine on sexual functioning

    Journal of Clinical Psychopharmacology, Vol. 25, Núm. 6, pp. 533-538